LH

LH

USD

Labcorp Holdings Inc. Common Stock

$252.720+5.880 (2.382%)

リアルタイム価格

Healthcare
Diagnostics & Research
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$246.840

高値

$252.760

安値

$244.520

出来高

0.69M

企業ファンダメンタルズ

時価総額

21.0B

業種

Diagnostics & Research

United States

取引統計

平均出来高

0.62M

取引所

NYQ

通貨

USD

52週レンジ

安値 $209.38現在値 $252.720高値 $293.72

関連ニュース

Analyst Upgrades

UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320

UBS analyst Kevin Caliendo maintains Labcorp Hldgs with a Buy and lowers the price target from $325 to $320.

もっと見る
UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320
Reuters

Labcorp cuts growth outlook for research unit as biotech funding crunch persists

Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to weigh on its early-stage drug development clients.

もっと見る
Labcorp cuts growth outlook for research unit as biotech funding crunch persists
Analyst Upgrades

Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support

Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong diagnostics and lab growth.

もっと見る
Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support
PR Newswire

Labcorp Announces 2025 Third Quarter Results

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the third quarter ended...

もっと見る
Labcorp Announces 2025 Third Quarter Results
PR Newswire

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the...

もっと見る
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings